Similar Papers

Paper Title
Journal
Date
Author
1372P - Risks and benefits of phase 1 oncology trials in the era of personalized medicine
C Chakiba ... A Italiano
Annals of Oncology | VOL. 27
C Chakiba, et. al.C Chakiba ... A Italiano
01 Oct 2016
Novel Therapies, High-Risk Pediatric Research, and the Prospect of Benefit: Learning from the Ethical Disagreements
Inmaculada De Melo-Martín ... Ronald G Crystal
Molecular Therapy | VOL. 20
Inmaculada De Melo-Martín, et. al.Inmaculada De Melo-Martín ... Ronald G Crystal
01 Jun 2012
Adaptive designs for single‐arm phase II trials in oncology
Stefan Englert ... Meinhard Kieser
Pharmaceutical Statistics | VOL. 11
Stefan Englert, et. al.Stefan Englert ... Meinhard Kieser
12 Mar 2012
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experience.
Francisco Bautista ... Dominique Couanet
Journal of Pediatric Hematology/Oncology | VOL. 37
Francisco Bautista, et. al.Francisco Bautista ... Dominique Couanet
01 Mar 2015
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy in patients with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma enrolled in the Republic of Korea: KEYNOTE-859.
Sun Young Rha ... Do-Youn Oh
Journal of Clinical Oncology | VOL. 43
Sun Young Rha, et. al.Sun Young Rha ... Do-Youn Oh
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.